[go: up one dir, main page]

WO2007138462A3 - Aqueous oral formulations of risperidone - Google Patents

Aqueous oral formulations of risperidone Download PDF

Info

Publication number
WO2007138462A3
WO2007138462A3 PCT/IB2007/001424 IB2007001424W WO2007138462A3 WO 2007138462 A3 WO2007138462 A3 WO 2007138462A3 IB 2007001424 W IB2007001424 W IB 2007001424W WO 2007138462 A3 WO2007138462 A3 WO 2007138462A3
Authority
WO
WIPO (PCT)
Prior art keywords
risperidone
oral formulations
aqueous oral
relates
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/001424
Other languages
French (fr)
Other versions
WO2007138462A2 (en
Inventor
Chandrashekhar Mainde
Rajendra Nandlal Nagori
Sai Hanuman Sagar Boddu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of WO2007138462A2 publication Critical patent/WO2007138462A2/en
Anticipated expiration legal-status Critical
Publication of WO2007138462A3 publication Critical patent/WO2007138462A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to stable aqueous solution of risperidone or salts thereof for oral administration. The invention also relates to processes for preparation of such formulations.
PCT/IB2007/001424 2006-06-01 2007-05-31 Aqueous oral formulations of risperidone Ceased WO2007138462A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN834/MUM/2006 2006-06-01
IN834MU2006 2006-06-01

Publications (2)

Publication Number Publication Date
WO2007138462A2 WO2007138462A2 (en) 2007-12-06
WO2007138462A3 true WO2007138462A3 (en) 2009-04-23

Family

ID=38779048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001424 Ceased WO2007138462A2 (en) 2006-06-01 2007-05-31 Aqueous oral formulations of risperidone

Country Status (1)

Country Link
WO (1) WO2007138462A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2457824C2 (en) * 2010-07-06 2012-08-10 Алексей Шамильевич Сюников Therapeutic and prophylactic toothpaste "stomatol"
GB2569940B (en) * 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
TW202510862A (en) * 2023-09-14 2025-03-16 大陸商上海雲晟研新生物科技有限公司 Risperidone solid oral film formulation, preparation method thereof, and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
US5616587A (en) * 1994-07-11 1997-04-01 Janssen Pharmaceutica N.V. Aqueous risperidone formulations
USRE39181E1 (en) * 1994-07-11 2006-07-11 Francois Marc Karel Jozef Aqueous risperidone formulations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JANSSEN ET AL.: "Pharmacology of Risperidone (R 64 766), a New Antipsychotic with Serotonin-S2 and Dopamine-D2 Antagonistic Properties", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS., vol. 244, no. 2, 1988, pages 685 - 693 *
LEYSEN ET AL.: "Biochemical Profile of Risperidone, a New Antipsychotic", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS., vol. 247, no. 2., 1988, pages 661 - 670 *
LOFTSSON ET AL.: "Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization", JOURNAL OF PHARMACEUTICAL SCIENCES., vol. 85, no. 10, October 1996 (1996-10-01), pages 1017 - 1025 *

Also Published As

Publication number Publication date
WO2007138462A2 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
WO2012021715A3 (en) Stable formulations of linaclotide
WO2011012816A3 (en) Pharmaceutical formulation
IL193074A0 (en) Stable pharmaceutical formulations of montelukast sodium
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2009115178A3 (en) Gingival wafer
WO2009032034A3 (en) Stabilized picoplatin dosage form
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
PL2076244T3 (en) Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
WO2008035359A3 (en) Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
WO2011006935A3 (en) Tetrazole derivatives
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2012037562A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
WO2011141488A3 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2009013545A3 (en) Chemical compounds
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010049449A3 (en) Novel salts of sunitinib
ZA201107412B (en) Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2007070517A3 (en) Fexofenadine suspension formulation
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
WO2007138462A3 (en) Aqueous oral formulations of risperidone
WO2007110765A3 (en) Processes for the preparation of octreotide
IL194094A0 (en) Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives
WO2006129160A3 (en) Stable aqueous oral solution of risperidone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07734715

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07734715

Country of ref document: EP

Kind code of ref document: A2